W Vogelhuber1, P Rotunno, E Magni
1Department of Pharmaceutical Technology, University of Regensburg, 93040, Regensburg, Germany.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
New pulsatile release implants offer controlled drug delivery for up to 58 days. These tiny, biocompatible devices can be programmed for timed substance release, aiding vaccination and tumor therapy.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: